The company announced positive Phase 1 results for a subcutaneous formulation of Briumvi, evaluating it against the currently ...

THIRUVANANTHAPURAM: Merin Theres John, a native of Pathanamthitta, was just 20 and sitting for her BCom examination when the ...

The benefits of frexalimab in people with relapsing MS have been sustained for up to three years in a clinical trial, data ...

Higher-dose ocrelizumab produced greater peripheral B-cell depletion than the approved 600 mg regimen in two phase 3b trials ...

The company on Wednesday said that a Phase 1 trial for a subcutaneous formulation of ublituximab, the active agent in its Briumvi drug, was well-tolerated and achieved sustained drug exposure. The ...

A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the ...

Immunic Inc (NASDAQ:IMUX, FRA:10VA) said on Thursday it presented three posters at the 2026 Consortium of Multiple Sclerosis ...

On World Multiple Sclerosis Day be warned hat blurred vision and eye pain may be early signs of the undiagnosed neurological ...

Neurophet has entered a collaboration to advance software that uses AI to examine brain MRI scans for signs characteristic of ...

DNA damage from inflammation outpaces the cells’ ability to self-repair. The finding, in human brain cells and mice, could point to new MS treatments.

A tingling sensation in the hand after waking up, unusual tiredness despite adequate rest, or occasional unsteadiness while walking are symptoms many young adults tend to dismiss. In a fast-paced ...